Overview of fluoroquinolone safety
- PMID: 1767803
- DOI: 10.1016/0002-9343(91)90330-z
Overview of fluoroquinolone safety
Abstract
The safety of the fluoroquinolone antimicrobial agents is reviewed, discussing documented and potential clinical and laboratory adverse effects and drug-drug interactions. In prospective, randomized, double-blind clinical trials comparing fluoroquinolones to nonquinolone drugs or placebo, the fluoroquinolones were not significantly different (22 studies) or were superior (5 studies) to comparison agents but were only rarely more toxic (2 studies). Adverse effects included mild gastrointestinal toxicities and less common but more problematic central nervous system toxicities. Clinically important interactions occurred with coadministration of antacids and all fluoroquinolones and with theophylline and enoxacin and to a lesser extent ciprofloxacin and pefloxacin but not other fluoroquinolones. Potential adverse effects such as cartilage damage, DNA damage, teratogenicity, and crystalluria, while of concern, have not as yet been shown to be of clinical importance. Therapy of bacterial infections in children and adolescents is relatively contraindicated, but growing clinical experience with treatment of these patients has not so far revealed serious bone or cartilage toxicity. The fluoroquinolones thus far have exhibited a favorable safety profile, but our clinical experience is still limited, and monitoring for as yet unappreciated toxicities is warranted.
Similar articles
-
Adverse reactions and interactions of fluoroquinolones.Clin Invest Med. 1989 Feb;12(1):28-34. Clin Invest Med. 1989. PMID: 2646053 Review.
-
Safety profile of the quinolones.J Antimicrob Chemother. 1990 Nov;26 Suppl D:31-44. doi: 10.1093/jac/26.suppl_d.31. J Antimicrob Chemother. 1990. PMID: 2286589 Review.
-
Tolerability of fluoroquinolone antibiotics. Past, present and future.Drug Saf. 1995 Dec;13(6):343-58. doi: 10.2165/00002018-199513060-00004. Drug Saf. 1995. PMID: 8652079 Review.
-
Overview of the fluoroquinolone antibiotics.Pharmacotherapy. 1993 Mar-Apr;13(2 Pt 2):4S-17S. Pharmacotherapy. 1993. PMID: 8386356 Review.
-
Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds.Antimicrob Agents Chemother. 1997 Nov;41(11):2389-93. doi: 10.1128/AAC.41.11.2389. Antimicrob Agents Chemother. 1997. PMID: 9371338 Free PMC article.
Cited by
-
Explorative Analysis of Treatment Outcomes of Levofloxacin- and Moxifloxacin-Based Regimens and Outcome Predictors in Ethiopian MDR-TB Patients: A Prospective Observational Cohort Study.Infect Drug Resist. 2021 Dec 18;14:5473-5489. doi: 10.2147/IDR.S342964. eCollection 2021. Infect Drug Resist. 2021. PMID: 34984005 Free PMC article.
-
Oxidative stress induced by fluoroquinolones on treatment for complicated urinary tract infections in Indian patients.J Young Pharm. 2011 Oct;3(4):304-9. doi: 10.4103/0975-1483.90242. J Young Pharm. 2011. PMID: 22224037 Free PMC article.
-
Non-fatal acute liver injury possibly related to high-dose ciprofloxacin.Eur J Clin Microbiol Infect Dis. 2003 May;22(5):294-6. doi: 10.1007/s10096-003-0914-6. Epub 2003 May 9. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12739107
-
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010. Drugs. 1996. PMID: 8736621 Review.
-
Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of Dicural.Vet Res Commun. 2005 May;29(4):297-304. doi: 10.1023/b:verc.0000048503.05426.68. Vet Res Commun. 2005. PMID: 15751581
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources